See more : Medicalgorithmics S.A. (MDG.WA) Income Statement Analysis – Financial Results
Complete financial analysis of MoneyGram International, Inc. (MGI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MoneyGram International, Inc., a leading company in the Financial – Credit Services industry within the Financial Services sector.
You may be interested
- EST Tools Co., Ltd (300488.SZ) Income Statement Analysis – Financial Results
- Chill Brands Group PLC (CHLL.L) Income Statement Analysis – Financial Results
- Harmonic Drive Systems Inc. (HSYDF) Income Statement Analysis – Financial Results
- Wintrust Financial Corporation (WTFCP) Income Statement Analysis – Financial Results
- The People’s Insurance Company (Group) of China Limited (1339.HK) Income Statement Analysis – Financial Results
MoneyGram International, Inc. (MGI)
Industry: Financial - Credit Services
Sector: Financial Services
Website: https://corporate.moneygram.com
About MoneyGram International, Inc.
MoneyGram International, Inc., together with its subsidiaries, provides cross-border peer-to-peer payments and money transfer services in the United States and internationally. The company operates through two segments, Global Funds Transfer and Financial Paper Products. The Global Funds Transfer segment offers money transfer services and bill payment services through third-party agents, including retail chains, independent retailers, post offices, banks, and other financial institutions; and digital solutions, such as moneygram.com, account deposit, and kiosk-based services, as well as mobile app solutions. The Financial Paper Products segment provides money orders to consumers through its agents and financial institutions under the MoneyGram brand and on a private label or co-branded basis with various agents and financial institutions; and official check outsourcing services for banks and credit unions. MoneyGram International, Inc. was incorporated in 2003 and is based in Dallas, Texas.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.31B | 1.28B | 1.22B | 1.29B | 1.45B | 1.60B | 1.63B | 1.43B | 1.45B | 1.47B | 1.34B | 1.25B | 1.17B | 1.17B | 927.12M | 157.54M | 1.16B | 971.24M | 826.53M | 737.22M | 1.28B | 305.97M |
| Cost of Revenue | 918.20M | 911.90M | 876.80M | 890.60M | 992.00M | 1.05B | 1.09B | 965.30M | 941.40M | 943.10M | 841.10M | 548.00M | 501.50M | 498.47M | 604.61M | 663.91M | 563.66M | 470.47M | 151.60M | 377.33M | 684.10M | 0.00 |
| Gross Profit | 391.90M | 371.70M | 340.40M | 394.50M | 455.60M | 552.20M | 539.70M | 469.40M | 513.50M | 531.30M | 500.10M | 699.77M | 665.16M | 673.44M | 322.51M | -506.37M | 595.90M | 500.76M | 674.94M | 359.89M | 599.50M | 305.97M |
| Gross Profit Ratio | 29.91% | 28.96% | 27.97% | 30.70% | 31.47% | 34.47% | 33.10% | 32.72% | 35.29% | 36.03% | 37.29% | 56.08% | 57.01% | 57.47% | 34.79% | -321.43% | 51.39% | 51.56% | 81.66% | 48.82% | 46.70% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 59.80M | 241.00M | 173.00M | 268.70M | 360.80M | 468.40M | 371.40M | 387.10M | 386.60M | 302.70M | 403.40M | 511.20M | 458.69M | 510.51M | 490.48M | 423.86M | 372.22M | 314.32M | 0.00 | 234.57M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 59.80M | 241.00M | 173.00M | 268.70M | 360.80M | 468.40M | 371.40M | 387.10M | 386.60M | 302.70M | 403.40M | 511.20M | 458.69M | 510.51M | 490.48M | 423.86M | 372.22M | 314.32M | 126.64M | 234.57M | 0.00 | 0.00 |
| Other Expenses | 238.90M | 57.00M | 64.40M | 73.80M | 24.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 525.80M | 0.00 |
| Operating Expenses | 298.70M | 298.00M | 237.40M | 342.50M | 437.10M | 543.50M | 451.30M | 453.20M | 442.10M | 353.40M | 447.70M | 557.25M | 506.76M | 567.60M | 547.15M | 475.84M | 411.20M | 346.78M | 609.81M | 261.86M | 525.80M | 0.00 |
| Cost & Expenses | 1.22B | 1.21B | 1.11B | 1.23B | 1.43B | 1.59B | 1.54B | 1.42B | 1.38B | 1.30B | 1.29B | 1.11B | 1.01B | 1.07B | 1.15B | 1.14B | 974.86M | 817.25M | 761.40M | 639.20M | 1.21B | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 395.49M | 367.99M | 0.00 | 323.10M | 0.00 | 0.00 |
| Interest Expense | 49.40M | 69.50M | 92.40M | 77.00M | 53.60M | 45.30M | 45.00M | 45.30M | 44.20M | 47.30M | 70.90M | 86.17M | 102.13M | 107.91M | 95.02M | 11.06M | 7.93M | 7.61M | 5.57M | 9.86M | 69.50M | 0.00 |
| Depreciation & Amortization | 47.70M | 53.30M | 59.90M | 73.80M | 76.30M | 75.10M | 79.90M | 66.10M | 55.50M | 50.70M | 44.30M | 46.05M | 48.07M | 57.09M | 56.67M | 51.98M | 38.98M | 32.47M | 29.57M | 27.30M | 57.00M | 27.15M |
| EBITDA | 140.90M | 127.00M | 162.90M | 86.50M | 119.00M | 83.80M | 168.30M | 82.30M | 126.90M | 228.60M | 96.30M | 188.57M | 206.47M | 162.93M | -167.97M | -930.23M | 223.68M | 186.45M | 145.44M | 125.32M | 82.90M | 333.12M |
| EBITDA Ratio | 10.75% | 9.89% | 13.38% | 6.73% | 8.22% | 5.23% | 10.32% | 5.74% | 8.72% | 15.50% | 7.18% | 15.11% | 17.70% | 13.90% | -18.12% | -590.49% | 19.29% | 19.20% | 62.77% | 17.00% | 6.46% | 108.87% |
| Operating Income | 93.20M | 73.70M | 103.00M | 12.70M | 18.50M | 8.70M | 88.40M | 16.20M | 71.40M | 177.90M | 52.40M | 142.52M | 158.40M | 85.59M | -337.19M | -993.27M | 184.70M | 153.98M | 65.13M | 98.03M | 73.70M | 305.97M |
| Operating Income Ratio | 7.11% | 5.74% | 8.46% | 0.99% | 1.28% | 0.54% | 5.42% | 1.13% | 4.91% | 12.07% | 3.91% | 11.42% | 13.58% | 7.30% | -36.37% | -630.50% | 15.93% | 15.85% | 7.88% | 13.30% | 5.74% | 100.00% |
| Total Other Income/Expenses | -53.40M | -117.30M | -96.90M | -77.00M | -29.40M | -45.30M | -45.30M | -45.30M | 1.20M | -92.60M | -61.30M | -102.75M | -100.02M | -87.66M | 0.00 | 0.00 | -7.93M | -7.61M | 23.89M | -9.86M | -117.30M | -246.02M |
| Income Before Tax | 39.80M | -43.60M | 6.10M | -64.30M | -10.90M | -36.60M | 43.10M | -29.10M | 72.60M | 85.30M | -8.90M | 39.77M | 58.38M | -2.07M | -337.19M | -993.27M | 176.77M | 146.38M | 89.02M | 88.17M | -43.60M | 59.95M |
| Income Before Tax Ratio | 3.04% | -3.40% | 0.50% | -5.00% | -0.75% | -2.28% | 2.64% | -2.03% | 4.99% | 5.79% | -0.66% | 3.19% | 5.00% | -0.18% | -36.37% | -630.50% | 15.24% | 15.07% | 10.77% | 11.96% | -3.40% | 19.59% |
| Income Tax Expense | 5.60M | -5.70M | 14.00M | -4.00M | 13.10M | -6.80M | 26.80M | 47.80M | 500.00K | 32.90M | 40.40M | -19.64M | 14.58M | -20.42M | -75.81M | 78.48M | 52.72M | 34.17M | 23.89M | 12.49M | -5.70M | -15.10M |
| Net Income | 34.20M | -37.90M | -7.90M | -60.30M | -24.00M | -29.80M | 16.30M | -76.90M | 72.10M | 52.40M | -49.30M | 59.41M | 43.80M | 18.34M | -261.39M | -1.07B | 124.05M | 112.95M | 86.41M | 113.90M | -37.90M | 75.05M |
| Net Income Ratio | 2.61% | -2.95% | -0.65% | -4.69% | -1.66% | -1.86% | 1.00% | -5.36% | 4.96% | 3.55% | -3.68% | 4.76% | 3.75% | 1.57% | -28.19% | -680.47% | 10.70% | 11.63% | 10.45% | 15.45% | -2.95% | 24.53% |
| EPS | 0.35 | -0.42 | -0.10 | -0.85 | -0.37 | -0.47 | 0.26 | -1.24 | 1.10 | 0.73 | -0.69 | -9.03 | -8.80 | -9.92 | -25.36 | -103.55 | 11.76 | 10.64 | 7.92 | 10.48 | -0.42 | 6.76K |
| EPS Diluted | 0.34 | -0.42 | -0.10 | -0.85 | -0.37 | -0.47 | 0.25 | -1.24 | 1.10 | 0.73 | -0.69 | -9.03 | -8.80 | -9.92 | -25.36 | -103.55 | 11.60 | 10.48 | 7.92 | 10.48 | -0.42 | 6.60K |
| Weighted Avg Shares Out | 96.40M | 89.70M | 77.80M | 71.10M | 64.30M | 62.90M | 62.30M | 62.10M | 65.30M | 71.60M | 71.50M | 48.60M | 10.40M | 10.31M | 10.31M | 10.35M | 10.54M | 10.58M | 10.86M | 10.78M | 89.70M | 11.10K |
| Weighted Avg Shares Out (Dil) | 100.10M | 89.70M | 77.80M | 71.10M | 64.30M | 62.90M | 65.90M | 62.10M | 65.50M | 71.90M | 71.50M | 48.60M | 10.40M | 10.31M | 10.31M | 10.35M | 10.73M | 10.75M | 10.92M | 10.83M | 89.70M | 11.37K |
MoneyGram International Reports Fourth Quarter and Full-Year 2022 Results
Digital revenue reached an all-time high of $98.6 million and digital transactions reached 47% of money transfer transactions at the end of the fourth quarter Digital transactions increased 47% in the fourth quarter over the prior year DALLAS , Feb....
Middle East & Africa Green Data Center Market Outlook Report 2022-2023 & 2027: Market will Witness Investments from CSPs, Such as Google, Amazon Web Services, Microsoft, Oracle, and Tencent - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Middle East & Africa Green Data Center Market - Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The Middle East and Africa green data center market is expected to reach a value of $1.58...
Worldwide Single Cell Analysis (SCA) Market Forecasted to Grow at 13% p.a. over the Next Three Years, Reaching $1.7B by 2025 – Market Report by DeciBio Consulting LLC
LOS ANGELES--(BUSINESS WIRE)--According to a comprehensive market report authored by DeciBio Consulting LLC, Single-Cell Analysis (SCA): Market Size, Segmentation, Growth, Competition, and Trends (2019-2025), the global single-cell analysis market is predicted to reach $1.7B by 2025. This growth will be...
Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Targeted Sequencing Market - A Global and Regional Analysis: Focus on Product Type, Target Enrichment Method, Type of Target Capture, Application, End User, and Region Analysis - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering....
Whole Genome and Exome Sequencing Markets Report 2023 with Direct to Consumer Analysis to 2027 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The report forecasts the market size out...
Integrated DNA Technologies Debuts Collab Network
CORALVILLE, Iowa--(BUSINESS WIRE)--With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT) has launched Collab Network, a first-of-its-kind IDT program aimed at uniting researchers and industry partners under a single, impactful research network to foster learning, collaboration...
Top 5 Tech Stocks That May Rally
The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
MoneyGram Provides Further Update on Timing of Closing of Merger Transaction with Madison Dearborn Partners
One Regulatory Approval Remains and Closing Now Expected End of Q1/Early Q2 DALLAS , Jan. 30, 2023 /PRNewswire/ -- MoneyGram International, Inc. (NASDAQ: MGI) (the "Company"), a leading global financial technology company that connects the world's communities, today provided an...
MoneyGram Joins Forces with BOTIM to Launch International Money Transfer to Over 200 Countries
BOTIM, the largest and most popular VoIP solution in MENA, is now the region's first communications platform to enable its users to seamlessly send money around the world Astra Tech, the owner of BOTIM, is the latest organization to embed...
MoneyGram Recognized as Top Workplace in the USA for Second Consecutive Year
The Company has been named a recipient of the 2023 Top Workplaces USA award, an honor based entirely on employee feedback as part of leading employer recognition program Top Workplaces The award measures culture drivers including employee alignment with the...
Source: https://incomestatements.info
Category: Stock Reports